BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29337110)

  • 1. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer.
    Fan K; Yang C; Fan Z; Huang Q; Zhang Y; Cheng H; Jin K; Lu Y; Wang Z; Luo G; Yu X; Liu C
    Cancer Lett; 2018 Apr; 418():167-175. PubMed ID: 29337110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma.
    Liang C; Qin Y; Zhang B; Ji S; Shi S; Xu W; Liu J; Xiang J; Liang D; Hu Q; Ni Q; Xu J; Yu X
    Mol Cancer Res; 2017 Feb; 15(2):201-212. PubMed ID: 28108627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.
    Turner MS; Kane LP; Morel PA
    J Immunol; 2009 Oct; 183(8):4895-903. PubMed ID: 19801514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells.
    Zhang S; Yong LK; Li D; Cubas R; Chen C; Yao Q
    PLoS One; 2013; 8(7):e68303. PubMed ID: 23874581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
    Matte I; Garde-Granger P; Bessette P; Piché A
    BMC Cancer; 2019 Apr; 19(1):406. PubMed ID: 31039761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-FOXP3 directly activated CCL5 to recruit FOXP3
    Wang X; Lang M; Zhao T; Feng X; Zheng C; Huang C; Hao J; Dong J; Luo L; Li X; Lan C; Yu W; Yu M; Yang S; Ren H
    Oncogene; 2017 May; 36(21):3048-3058. PubMed ID: 27991933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC16 C-terminal binding with ALDOC disrupts the ability of ALDOC to sense glucose and promotes gallbladder carcinoma growth.
    Fan K; Wang J; Sun W; Shen S; Ni X; Gong Z; Zheng B; Gao Z; Ni X; Suo T; Liu H; Liu H
    Exp Cell Res; 2020 Sep; 394(1):112118. PubMed ID: 32502493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.
    Das S; Rachagani S; Torres-Gonzalez MP; Lakshmanan I; Majhi PD; Smith LM; Wagner KU; Batra SK
    Oncotarget; 2015 Mar; 6(8):5772-87. PubMed ID: 25691062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells.
    Raffin C; Raimbaud I; Valmori D; Ayyoub M
    J Immunol; 2011 Nov; 187(10):5196-202. PubMed ID: 21998454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helios Enhances Treg Cell Function in Cooperation With FoxP3.
    Takatori H; Kawashima H; Matsuki A; Meguro K; Tanaka S; Iwamoto T; Sanayama Y; Nishikawa N; Tamachi T; Ikeda K; Suto A; Suzuki K; Kagami S; Hirose K; Kubo M; Hori S; Nakajima H
    Arthritis Rheumatol; 2015 Jun; 67(6):1491-502. PubMed ID: 25733061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
    Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
    Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
    Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
    Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
    Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
    J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.
    Shukla SK; Gunda V; Abrego J; Haridas D; Mishra A; Souchek J; Chaika NV; Yu F; Sasson AR; Lazenby AJ; Batra SK; Singh PK
    Oncotarget; 2015 Aug; 6(22):19118-31. PubMed ID: 26046375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
    Rao TD; Tian H; Ma X; Yan X; Thapi S; Schultz N; Rosales N; Monette S; Wang A; Hyman DM; Levine DA; Solit D; Spriggs DR
    PLoS One; 2015; 10(5):e0126633. PubMed ID: 25965947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function.
    Pillemer BB; Xu H; Oriss TB; Qi Z; Ray A
    Eur J Immunol; 2007 Aug; 37(8):2082-9. PubMed ID: 17621372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of human thymic regulatory T cells at the double positive stage.
    Nunes-Cabaço H; Caramalho I; Sepúlveda N; Sousa AE
    Eur J Immunol; 2011 Dec; 41(12):3604-14. PubMed ID: 21932449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.